[go: up one dir, main page]

MX2018001841A - Composiciones de mycoplasma bovis. - Google Patents

Composiciones de mycoplasma bovis.

Info

Publication number
MX2018001841A
MX2018001841A MX2018001841A MX2018001841A MX2018001841A MX 2018001841 A MX2018001841 A MX 2018001841A MX 2018001841 A MX2018001841 A MX 2018001841A MX 2018001841 A MX2018001841 A MX 2018001841A MX 2018001841 A MX2018001841 A MX 2018001841A
Authority
MX
Mexico
Prior art keywords
compositions
bovis
mycoplasma bovis
disclosed
mycoplasma
Prior art date
Application number
MX2018001841A
Other languages
English (en)
Other versions
MX389685B (es
Inventor
Francis Browning Glenn
Francis Markham Philip
Serge Marenda Marc
H Weber Fred
Mahan Suman
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2018001841A publication Critical patent/MX2018001841A/es
Publication of MX389685B publication Critical patent/MX389685B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen aquí composiciones inmunogénicas de Mycoplasma bovis útiles en aumentar una respuesta inmune en animales contra M. bovis; también se describen aquí métodos para generar una respuesta protectora contra infecciones en mamíferos causadas por M. bovis.
MX2018001841A 2015-08-14 2016-08-11 Composiciones de mycoplasma bovis. MX389685B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562205125P 2015-08-14 2015-08-14
PCT/US2016/046572 WO2017030901A1 (en) 2015-08-14 2016-08-11 Mycoplasma bovis compositions

Publications (2)

Publication Number Publication Date
MX2018001841A true MX2018001841A (es) 2018-08-01
MX389685B MX389685B (es) 2025-03-20

Family

ID=56800367

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001841A MX389685B (es) 2015-08-14 2016-08-11 Composiciones de mycoplasma bovis.

Country Status (22)

Country Link
US (2) US11389518B2 (es)
EP (2) EP3334454B1 (es)
JP (1) JP6675484B2 (es)
CN (3) CN108135989B (es)
AU (2) AU2016307935B2 (es)
BR (1) BR112018002919B1 (es)
CA (1) CA2995101A1 (es)
CY (2) CY1125699T1 (es)
DK (1) DK3334454T3 (es)
ES (1) ES2933623T3 (es)
FI (1) FI3334454T3 (es)
FR (1) FR23C1037I2 (es)
HR (1) HRP20221440T1 (es)
HU (2) HUE060545T2 (es)
LT (1) LT3334454T (es)
MX (1) MX389685B (es)
NL (1) NL301244I2 (es)
PL (1) PL3334454T3 (es)
PT (1) PT3334454T (es)
SI (1) SI3334454T1 (es)
WO (1) WO2017030901A1 (es)
ZA (1) ZA201800956B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN111471695A (zh) * 2020-05-11 2020-07-31 吉林农业大学 牛支原体免疫磁珠的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
EP0575491B1 (en) 1991-03-07 2003-08-13 Virogenetics Corporation Genetically engineered vaccine strain
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
WO1993013302A1 (de) 1991-12-23 1993-07-08 Michael Zoche Motor mit einer vorrichtung zur entölung
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
CN1217027A (zh) 1996-02-28 1999-05-19 拜尔公司 含外源dna的副痘病毒,其制备及其在疫苗中的应用
EP0958364A4 (en) 1996-10-23 2001-10-31 Univ Pennsylvania IMMUNOTHERAPY AND IMPROVED VACCINES
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
KR100743894B1 (ko) 1998-02-27 2007-07-30 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 백신, 면역치료제 및 그의 이용 방법
DE69925113T2 (de) 1998-03-13 2006-01-19 Wyeth Polynukleotidzusammensetzung, verfahren zu deren herstellung und verwendung
JP4673974B2 (ja) 1998-09-30 2011-04-20 ワイス・ホールディングズ・コーポレイション アジュバントとしての変異コレラホロトキシン
EP1229929A2 (en) 1999-11-08 2002-08-14 Biomune VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
GB0110851D0 (en) 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
CN1297316C (zh) 2001-06-07 2007-01-31 惠氏控股有限公司 作为佐剂的霍乱全毒素的突变体形式
EP1404279A4 (en) 2001-06-07 2007-08-08 Wyeth Corp MUTANT FORMS OF CHOLERA HOLOTOXIN AS ADJUVANT
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
CA2515890C (en) 2003-02-20 2013-09-17 Therion Biologics Corporation Novel insertion sites in pox vectors
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
CA2729080C (en) 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
WO2010051210A1 (en) * 2008-10-31 2010-05-06 Boehringer Ingelheim Vetmedica, Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
EP2398892A4 (en) * 2009-02-20 2013-03-06 Australian Poultry Crc Pty Ltd LIVING WEARED VACCINES
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
CY2023020I2 (el) 2024-02-16
FR23C1037I1 (fr) 2023-12-08
BR112018002919B1 (pt) 2024-02-27
CY2023020I1 (el) 2024-02-16
CN108135989A (zh) 2018-06-08
US11389518B2 (en) 2022-07-19
FI3334454T3 (fi) 2023-01-13
NZ778923A (en) 2025-05-02
LT3334454T (lt) 2022-12-27
NL301244I1 (nl) 2023-10-04
ZA201800956B (en) 2018-12-19
NZ739767A (en) 2025-05-02
JP6675484B2 (ja) 2020-04-01
US20190255166A1 (en) 2019-08-22
AU2016307935B2 (en) 2022-08-18
AU2022231761A1 (en) 2022-10-06
AU2016307935A1 (en) 2018-02-22
CA2995101A1 (en) 2017-02-23
SI3334454T1 (sl) 2023-02-28
PT3334454T (pt) 2022-12-20
EP3334454B1 (en) 2022-10-19
BR112018002919A2 (pt) 2018-09-18
HUS2300032I1 (hu) 2024-07-28
ES2933623T3 (es) 2023-02-10
EP4137152A1 (en) 2023-02-22
PL3334454T3 (pl) 2023-01-30
MX389685B (es) 2025-03-20
CN108135989B (zh) 2022-08-09
DK3334454T3 (da) 2022-11-14
US20220296694A1 (en) 2022-09-22
CN115141773A (zh) 2022-10-04
CN115141772A (zh) 2022-10-04
CY1125699T1 (el) 2024-02-16
HK1251478A1 (en) 2019-02-01
HUE060545T2 (hu) 2023-03-28
WO2017030901A1 (en) 2017-02-23
FR23C1037I2 (fr) 2025-12-19
JP2018523708A (ja) 2018-08-23
HRP20221440T1 (hr) 2023-02-03
EP3334454A1 (en) 2018-06-20
AU2022231761B2 (en) 2025-09-18
NL301244I2 (nl) 2023-11-01

Similar Documents

Publication Publication Date Title
PH12016502142A1 (en) Anti-ptk7 antibody-drug conjugates
LT3307288T (lt) Kompozicijos, apimančios bakterijų kamienus
LT3206700T (lt) Kompozicijos, apimančios bakterijų kamienus
BR112017010874A2 (pt) composição para impressão tridimensional, composição e objeto tridimensional
LT3549592T (lt) Kompozicijos, apimančios bakterijų kamienus
BR112017009374A2 (pt) ?composições de ramnolipídeo de baixa viscosidade concentradas?
IL248239A0 (en) Drug conjugates - antibody against - her3, preparations containing them and their uses
PT3436054T (pt) Composições de toxina clostridial não proteicas estabilizadas
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
MX2017016401A (es) Composiciones inmunogenas.
ZA201902563B (en) Expec glycoconjugate vaccine formulations
EP2955192A4 (en) ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
PL3402802T3 (pl) Kompozycje i sposoby generowania odpowiedzi immunologicznej względem antygenu powiązanego z guzem nowotworowym
LT3638271T (lt) Kompozicijos, apimančios bakterines padermes
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
MX2017009810A (es) Derivado de nitroimidazol contra tuberculosis pulmonar.
CY1125699T1 (el) Συνθεσεις mycoplasma bovis
EP3283102A4 (en) Bordetella pertussis immunogenic vaccine compositions
EA201690378A1 (ru) Вакцинные композиции против наркотической зависимости
GB201604755D0 (en) Immunogenic compositions
SG11202106494RA (en) Compositions, methods and uses for eliciting an immune response
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
MX2018005134A (es) Formulacion de factor viii (fviii).
MX2017002594A (es) Vacuna para sistemas de produccion ganadera.
ITUA20163369A1 (it) Guida di estrazione per cassetti o simili dotata di mezzi di regolazione.